Volume 11, number 3

The Role of MCP-1(Monocyte Chemoattractant Protein-1) in Restenosis

Hoda Mohammad Dezashibi and Hossein Khanahmad*

Department of Genetics and Molecular Biology, Isfahan Medicine School, Isfahan University of Medical Science, Isfahan, Iran.

DOI : http://dx.doi.org/http://dx.doi.org/10.13005/bbra/1518

ABSTRACT:

Monocyte chemoattractant protein-1 (MCP-1) is a monomeric polypeptide with a low molecular weight that its major activity is associated with monocytes. The polypeptide causes the expression of e-selectin and the infiltration of monocytes into the subendothelial space by inducing a lasting impact on monocytes. MCP-1 activity also activates monocytes and the express of tissue factor (TF), superoxide anions and proinflammatory genes. Other roles identified for MCP-1 is the direct impact of polypeptide on restenosis after surgery. This review article is aimed to use the available resources of database in relation to MCP-1 to discuss in detail about the clinical significances, the signaling pathways in which MCP-1 play a role, gene polymorphism and its effects, the role of MCP-1 in vascular disease, particularly the role in the artery reclogging and finally the gene therapy mediated by MCP-1- inhibition on restenosis.

KEYWORDS: MCP-1; Restenosis; Monocytes

Download this article as: 
Copy the following to cite this article:

Dezashibi H. M, Khanahmad H. The Role of MCP-1(Monocyte Chemoattractant Protein-1) in Restenosis. Biosci Biotech Res Asia 2014;11(3).
Copy the following to cite this URL:

Dezashibi H. M, Khanahmad H. The Role of MCP-1(Monocyte Chemoattractant Protein-1) in Restenosis. Biosci Biotech Res Asia 2014;11(3). Available from: https://www.biotech-asia.org/?p=10347

[ HTML Full Text]

Back to TOC